Serum enhanced cytokine responses of macrophages to silica and iron oxide particles and nanomaterials: A comparison of serum to lung lining fluid and albumin dispersions

Journal of Applied Toxicology

Volumn 34, Issue 11, 2014, Pages 1177-1187

  Brown, David M ^a   Johnston, Helinor ^a   Gubbins, Eva ^a   Stone, Vicki ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Cytokine; Dispersant; Iron oxide; J774; Nanomaterials; Silica

Indexed keywords

BOVINE SERUM ALBUMIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON OXIDE NANOPARTICLE; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG; ALBUMINOID; CCL2 PROTEIN, HUMAN; FERRIC ION; FERRIC OXIDE; NANOMATERIAL; SILICON DIOXIDE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXICITY; DISPERSION; ENZYME RELEASE; LUNG FLUID; LUNG LAVAGE; MACROPHAGE CULTURE; MACROPHAGE FUNCTION; MALE; MOUSE; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SERUM; SURFACE CHARGE; SURFACE PROPERTY; ANIMAL; BLOOD; BODY FLUID; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; LUNG; MACROPHAGE; METABOLISM; SPRAGUE DAWLEY RAT;

ALBUMINS; ANIMALS; BODY FLUIDS; CHEMOKINE CCL2; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; LUNG; MACROPHAGES; MALE; NANOSTRUCTURES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE;

EID: 84907874839     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2998     Document Type: Article

References (38)

1. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61: 428-437.
2. Balbus JM, Maynard AD, Colvin VL, Castranova V, Daston GP, Denison RA, Dreher KL, Goering PL, Goldberg AM, Kulinowski KM, Monteiro-Riviere NA, Oberdorster G, Omenn GS, Pinkerton KE, Ramos KS, Rest KM, Sass JB, Silbergeld EK, Wong BA. 2007. Meeting Report: hazard assessment for NPs - report from an interdisciplinary workshop. Env. Hlth Perspect. 115 (11): 1654-1659.
3. Baughman RP, Mangels DJ, Strohofer S, Corser BC. 1987. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid. J. Lab. Clin. Med. 109 (6): 692-697.
4. Brown DM, Dickson C, Duncan P, Al-Attili F, Stone V. 2010. Interaction between NPs and cytokine proteins: impact on protein and particle functionality. Nanotechnology 21: 215104.
5. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 175: 191-199.
6. Brown DM, Kanase N, Gaiser B, Johnston HJ, Stone V. 2013a. Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge. Tox. Letts. 224 (1): 147-156.
7. Brown DM, Johnston HJ, Gubbins E, Stone V. 2013b. Cytotoxicity and cytokine release in rat hepatocytes, C3A cells and macrophages exposed to gold nanoparticles - effect of biological dispersion media or corona. J. Biomed. Nanotech. (in press).
8. Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. 1996. Development of superparamagnetic nanoparticles for MRI. J. Microencapsul. 13 (3): 245-255.
9. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. 2007. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28: 2959-2966.
10. Donaldson K, Borm PJA. 1998. The quartz hazard: a variable entity. Ann. Occup. Hyg. 42: 287-294.
11. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdorster G, McGrath JL. 2009. The influence of protein adsorption on nanoparticles association with cultured endothelial cells. Biomaterials 30: 603-610.
12. Fröhlich E. 2012. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7: 5577-5591.
13. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22: 969-976.
14. Hoopes PJ, Strawbridge RR, Gibson UJ, Zeng Q, Pierce ZE, Savellano M, Tate JA, Ogden JA, Baker I, Foreman AR, Ivkov R. 2007. Intratumoral iron oxide nanoparticle hyperthermia and radiation cancer treatment. In Thermal Treatment of Tissue: Energy Delivery and Assessment IV, Proc. Of SPIE, 6440, 6440K; Ryan TP (ed.).
15. Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL, Liu HM. 2008. Macrophage physiological function after superparamagnetic iron oxide labelling. NMR Biomed. 21: 820-829.
16. Ishii H, Hayashi S, Hogg JC, Fujii T, Goto Y, Sakamoto N, Mukae H, Vincent R, van Eeden SF. 2005. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir. Res. 6: 87.
17. Jani PU, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42: 821
18. Johnston HJ, Semmler-Behnke M, Brown DM, Kreyling W, Tran L, Stone V. 2010. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol. Appl. Pharmacol. 242: 66-78.
19. Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Thomas Kissel T, Parak WJ, Kreyling WG. 2010. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31: 6574e6581.
20. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 105: 14265-14270.
21. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. 2007. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135: 167-174.
22. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. 2010. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133: 2525-2534.
23. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, Dinda AK. 2010. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int. J. Nanomedicine 5: 983-989.
24. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mat. 8: 543-557.
25. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health 65: 1531-1543.
26. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K. 2010. Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology 275 (1-3): 65-71.
27. Passagne I, Morille M, Rousset M, Pujalté I, L'azou B. 2012. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology 299 (2-3): 112-124.
28. Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H. 2008. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity and cellular uptake studies. Eur. J. Pharm. Biopharm. 68: 129-137.
29. Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew ME, Castranova V. 2008. A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2 (3): 144-154.
30. Rothen-Rutishauser B, Brown DM, Piallier-Boyles M, Kinloch IA, Windle AH, Gehr P, Stone V. 2010. Relating the physiochemical characteristics and dispersion of multiwalled carbon nanotubes to their oxidative reactivity in vitro and inflammation in vitro. Nanotoxicology 4 (3): 331-342.
31. Schleh C, Hohlfeld JM. 2009. Interaction of nanoparticles with the pulmonary surfactant system. Inhal. Toxicol. 21 (Suppl 1): 97-103.
32. Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schäffler M, Schmid G, Simon U, Kreyling WG. 2012. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 6: 36-46.
33. Soenen SJ, Himmelreich U, Nuytten N, De Cuyper M. 2011. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32 (1): 195-205.
34. Stayton I, Winiarz J, Shannon K. 2009. Study of uptake and loss of silica nanoparticles in living human lung epithelial cells at single cell level. Anal. Bioanal. Chem. 394: 1595-1608.
35. Tsai CP, Hung Y, Chou YH, Huang DM, Hsiao JK, Chang C, Chen YC, Mou CY. 2008. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 4 (2): 186-191.
36. Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW. 2012. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134: 2139-2147.
37. World Health Organization International Agency for Research on Cancer. 1997. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Crystalline silica - inhaled in the form of quartz or cristobalite from occupational sources (Group 1). Amorphous silica (Group 3) Vol 68 41.
38. Yoo JW. 2012. Toward improved selectivity of targeted delivery: the potential of magnetic nanoparticles. Arch. Pharm. Res. 35: 1-2.